ArticleHealth science reports2026
Hematological Indices Abnormalities Among Sudanese Children With Down Syndrome.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Down syndrome (DS) is a genetic condition caused by the triplication of chromosome 21. Currently, there is no available published data on hematological parameters among Sudanese children with Down syndrome. Therefore, this study aimed to investigate these parameters among this population. Methods: Blood samples were collected from children at Farouk Center and Al-Sababi Hospital in Khartoum State from July to December 2022. The samples were analyzed using a hematological analyzer, and the data were entered into a computer, examined, verified, and analyzed using the GraphPad Prism program. Results: No statistically significant differences were observed between patients and controls concerning age and gender ( Conclusion: The study showed that Down syndrome has a clear effect on certain blood parameters, including lower platelet levels and MCHC. A significant difference was observed between the Down syndrome group and the control group in complete blood count (CBC) and coagulation parameters. The study recommends conducting similar studies for further insights and improvements in understanding the hematological effects of Down syndrome.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.